Drug Profile
Levodopa controlled release - APeT
Alternative Names: ConstaDopa; Levodopa - APeTLatest Information Update: 10 Dec 2021
Price :
$50
*
At a glance
- Originator APeT
- Class Antiasthmatics; Antiparkinsonians; Catecholamines; Small molecules
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for clinical-Phase-Unknown development in Parkinson's-disease in Netherlands (PO, Controlled release)
- 04 Jan 2017 Chemical structure information added
- 13 Dec 2016 Clinical trials in Parkinson's disease in Netherlands (PO) before December 2016